Daijiworld

Saudi Arabia becomes first country to approve Anktiva for advanced lung and bladder cancer

The Saudi Food and Drug Authority (SFDA) has granted conditional approval for Anktiva, a groundbreaking cancer therapy, for ...

Saudi Arabia become world's first to conditionally approve Anktiva for advanced lung cancer

Saudi Arabia leads the way as the first country to grant conditional approval for Anktiva, a groundbreaking treatment for ...
WSKG

For those with addiction, going into and coming out of prison can be a minefield.

Many jails and prisons around the country don't provide medication treatment for opioid use disorder. Studies show that ...
Technology Networks

Simulations Could Help Predict and Improve Antibody Drug Formulations

A new computer model could help predict and improve antibody drug formulations. The goal is for patients to be able to ...

Rani Therapeutics Initiates Phase 1 Study of RT-114 RaniPill® for the Treatment of Obesity in Collaboration with ProGen

Detailed price information for Rani Therapeutics Holdings Inc Cl A (RANI-Q) from The Globe and Mail including charting and trades.
Saudi Gazette on MSN

SFDA approves registration of 'Anktiva' for treatment of bladder and lung cancer

The Saudi Food and Drug Authority (SFDA) has granted conditional approval for Anktiva (nogapendekin alfa inbakicept) in ...

Coya Therapeutics Reports Positive Frontotemporal Dementia Study Data

Detailed price information for Coya Therapeutics Inc (COYA-Q) from The Globe and Mail including charting and trades.

AbbVie Announces Topline Results for Epcoritamab (DuoBody CD3xCD20) from Phase 3 EPCORE DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Based on the topline results from the EPCORE® DLBCL-1 trial, AbbVie along with partner Genmab will engage global regulatory authorities to discuss next steps NORTH ...